Respiratory syncytial virus, or RSV, often causes cold-like symptoms, but it can lead to serious lower-respiratory illness in older adults. Age, frailty, chronic heart or lung disease, immune-system problems and residence in long-term care can increase the risk of severe illness.
An RSV vaccine may reduce the risk of serious RSV disease for eligible adults. However, the recommended age, publicly funded eligibility and preferred timing differ among countries and can change as health authorities review new evidence. The safest approach is to check the current guidance where you live and discuss your own risk with a qualified healthcare professional.
Why RSV matters more with age
RSV spreads through respiratory droplets and contaminated surfaces. Symptoms can include a runny nose, cough, reduced appetite, fever and wheezing. In some older adults, infection can progress to pneumonia or worsen an existing heart or lung condition.
The United States Centers for Disease Control and Prevention identifies adults aged 75 and older, people with chronic heart or lung disease, people with weakened immune systems and nursing-home residents among those at higher risk of severe RSV illness. Risk is not determined by age alone, so a personal assessment still matters.
Who is currently advised to consider vaccination?
Recommendations are not identical across English-speaking countries. As of November 2026:
- United States: the CDC recommends one RSV vaccine dose for everyone aged 75 or older and for adults aged 50 to 74 who have an increased risk of severe RSV illness.
- United Kingdom: the NHS offers vaccination to adults aged 75 or older, older-adult care-home residents and certain adults aged 65 to 74 with immunosuppression or a high-risk chronic respiratory condition. Local eligibility rules apply.
- Canada: the National Advisory Committee on Immunization strongly recommends RSV immunization for adults aged 75 or older and adults aged 65 to 74 at increased risk. Publicly funded access varies by province or territory.
- Australia: the Australian Immunisation Handbook recommends one dose for all adults aged 75 or older. Adults aged 60 to 74 may also consider vaccination, particularly when risk factors are present, but funding and access depend on the individual and programme rules.
These summaries are a starting point, not a substitute for local advice. Product authorization is also different from a public-health recommendation or a publicly funded programme. A vaccine can be licensed for an age group without being routinely funded for everyone in that group.
Risk factors worth discussing
An adult below the routine age threshold may still qualify because of health or living circumstances. Ask a healthcare professional whether the following affect eligibility:
- chronic lung disease, including chronic obstructive pulmonary disease;
- chronic heart disease;
- a weakened immune system or immune-suppressing treatment;
- advanced kidney disease or dialysis;
- diabetes with complications;
- frailty or difficulty clearing respiratory secretions;
- residence in a nursing home, care home or other long-term-care setting; or
- limited access to urgent medical care if illness becomes severe.
A diagnosis does not automatically mean that vaccination is appropriate, and this list is not exhaustive. The clinician can consider age, previous vaccination, allergies, current health, medicines and local recommendations together.
Is the RSV vaccine annual?
In the United States, the CDC states that the adult RSV vaccine is not currently an annual vaccine. A person who has already received a dose should not receive another dose at this time unless future guidance changes. Canadian and Australian authorities likewise describe current adult programmes around a single dose while evidence on the need for revaccination continues to develop.
Do not assume that a previous dose has “expired” simply because another RSV season has arrived. Before booking, check your vaccination record and tell the healthcare professional which RSV product you received and when. If the record is unclear, a pharmacy, clinic or immunization registry may be able to help.
When is the best time to receive it?
Timing depends on the local RSV season. The CDC says eligible adults in most of the continental United States gain the most benefit when vaccinated in late summer or early autumn, although vaccination can be given at other times. In Australia, where seasonal patterns differ, the national handbook advises offering vaccination before the usual RSV season where possible.
Do not delay an offered dose solely because a general article names a different month. Local circulation, appointment availability and personal risk can affect timing. Ask the vaccinating professional what is recommended in your area.
Can RSV and other vaccines be given together?
The CDC permits RSV vaccination at the same visit as other adult vaccines. Receiving more than one vaccine at a visit may increase common short-term effects such as injection-site pain, headache, muscle aches or fever. Other countries may use different programme guidance or appointment arrangements.
If you are also due for influenza, COVID-19, shingles, pneumococcal or another vaccine, bring your complete record. The clinician or pharmacist can help decide whether to give vaccines together or at separate appointments. Our vaccines for older adults overview can help you prepare a list, but local schedules remain authoritative.
Possible side effects and safety questions
Common vaccine reactions may include pain where the injection was given, tiredness, headache, muscle or joint pain, fever, nausea or swelling. They usually resolve without treatment, but ask the vaccinating professional what to expect and how to report a concern.
Tell the professional about any previous severe allergic reaction to a vaccine or vaccine ingredient. Seek emergency help for signs of a severe allergic reaction, such as difficulty breathing, swelling of the face or throat, a widespread rash, dizziness or weakness after vaccination.
Health authorities continue to monitor rare adverse events, including Guillain-Barré syndrome. This does not mean that most recipients will develop the condition. A healthcare professional can explain the known benefits and risks in the context of your age and health.
Questions to take to an appointment
- Am I eligible under the current programme where I live?
- Do my medical conditions or medicines increase my risk from RSV?
- Have I already received an RSV vaccine, and do I need another dose?
- Is there a preferred time of year for me to receive it?
- Can it be given with my other scheduled vaccines?
- Is it publicly funded, covered by insurance or available privately?
- Which side effects should I expect, and when should I seek help?
Bring your medication list, allergies and vaccination record. The doctor appointment checklist can help you organize these details, while the guide to managing multiple chronic conditions can help you prepare questions when several health issues affect the decision.
Vaccination is one part of respiratory protection
Vaccination does not prevent every RSV infection and does not replace everyday precautions. During periods of respiratory-virus circulation, consider improving indoor ventilation, washing hands, avoiding close contact when ill and following local public-health advice. People at higher risk may also wish to ask household members and caregivers how to reduce exposure.
Seek prompt medical advice if an older adult develops worsening breathing difficulty, dehydration, chest pain, confusion, blue or grey lips or skin, or rapidly worsening illness. Call local emergency services for severe breathing difficulty or another medical emergency.
Keep the decision organized
The Healthy Aging System is an educational framework for organizing health records, routines and appointment questions. It can help you record vaccine dates and prepare for a conversation with a healthcare professional, but it does not determine eligibility or replace individualized medical care.
This article provides general educational information and is not medical advice, diagnosis or treatment. Vaccine recommendations and funding rules change and vary by country. Check your national or local health authority and consult a qualified healthcare professional before vaccination.
Sources
- US Centers for Disease Control and Prevention: RSV Vaccines for Adults
- US Centers for Disease Control and Prevention: RSV Vaccine Guidance for Adults
- National Health Service: RSV Vaccine
- Public Health Agency of Canada: 2026 NACI RSV Vaccine Guidance
- Australian Immunisation Handbook: Respiratory Syncytial Virus